An Ever Growing Portfolio of Diverse Healthcare Companies

Produces the Impella product line, the world's smallest, minimally invasive, high performance micro blood pump with integrated motors and sensors

Enables employers to control costs with a benefits strategy that provides employees with a choice of competing health plans, provider networks, benefit products, plan designs and price points

Produces injectable implant products used in minimally invasive soft tissue augmentation procedures

Emerging biopharmaceutical company which develops novel products to address unmet medical needs

Identifies novel anti-cancer agents that combine the efficacy of cytotoxics with the tumor cell selectivity of modern targeted therapeutics.

Develops innovative cardiovascular products

Develops topical formulations for pharmaceutical and biotech companies

Develops a therapeutic platform that combines the best-in-class light activated drug and novel light generation devices to destroy tumors from the inside out

Develops proprietary technology for noninvasive cosmetic surgery applications

Focuses on acquiring and developing novel, small-molecule therapeutics for the US market

Developing an intraocular epiretinal radiation device to treat we Age-Related Macular Degeneration (AMD)

Develops noninvasive robotically controlled treatments for inflammatory and neovascular diseases of the eye

Develops and commercializes branded cardiovascular injectable products

Applies state-of-the-art semiconductor technology to the treatment of cardiovascular disease

Specialty oncology company which develops imaging and therapeutic products

Develops a method to produce antigen-specific human polyclonal antibody preparations

Serves as a health maintenance organization to New York City

Develops risk-sensitive in-licensed cancer drugs to address unmet medical needs